Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Amarillo Biosciences initiates clinical trial with interferon alfa in bone marrow disorders

April 28, 1997

Altarex receives funding for photodynamic therapy for ovarian cancer research

April 28, 1997

Bioniche reports positive clinical results for Regressin

April 25, 1997

BTG licenses Campath-1H to LeukoSite

April 25, 1997

Cel-Sci initiates clinical trial of Multikine in Israel

April 24, 1997

Medarex presents MDX-220 preclinical data at AACR

April 21, 1997

Supplemental BLA submitted in U.S. for Proleukin

April 16, 1997

Antitumor activity of Ono-4007 related to TNF induction

April 7, 1997

CAT and Techniclone to initiate trials for tumor therapy

March 27, 1997

Bristol-Myers Squibb discovers new ribosome-inactivating protein

March 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...